{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:28:30Z","timestamp":1788629310559,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD061222"],"award-info":[{"award-number":["U54HD061222"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD083211"],"award-info":[{"award-number":["U54HD083211"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002243"],"award-info":[{"award-number":["UL1TR002243"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016499","name":"Rett Syndrome Research Trust","doi-asserted-by":"publisher","award":["0281901.096"],"award-info":[{"award-number":["0281901.096"]}],"id":[{"id":"10.13039\/100016499","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10803-024-06238-0","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T03:01:51Z","timestamp":1709607711000},"page":"997-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Psychometric Assessment of the Rett Syndrome Caregiver Assessment of Symptom Severity (RCASS)"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3791-3367","authenticated-orcid":false,"given":"Melissa","family":"Raspa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gwaltney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Bann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"von Hehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika U.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Percy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Neul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"key":"6238_CR1","volume-title":"Aberrant behavior checklist\u2014Community","author":"MG Aman","year":"1994","unstructured":"Aman, M. G., & Singh, N. B. (1994). Aberrant behavior checklist\u2014Community. Slosson Educational Publications."},{"issue":"2","key":"6238_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23(2), 185\u2013188. https:\/\/doi.org\/10.1038\/13810","journal-title":"Nature Genetics"},{"issue":"2","key":"6238_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/1096-8628(200022)97:2<147::aid-ajmg6>3.0.co;2-o","volume":"97","author":"RE Amir","year":"2000","unstructured":"Amir, R. E., & Zoghbi, H. Y. (2000). Rett syndrome: Methyl-CpG-binding protein 2 mutations and phenotype\u2013genotype correlations. American Journal of Medical Genetics, 97(2), 147\u2013152. https:\/\/doi.org\/10.1002\/1096-8628(200022)97:2%3C147::aid-ajmg6%3E3.0.co;2-o","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"6238_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-015-9127-4","volume":"7","author":"KV Barnes","year":"2015","unstructured":"Barnes, K. V., Coughlin, F. R., O\u2019Leary, H. M., Bruck, N., Bazin, G. A., Beinecke, E. B., & Kaufmann, W. E. (2015). Anxiety-like behavior in Rett syndrome: Characteristics and assessment by anxiety scales. Journal of Neurodevelopmental Disorders, 7(1), 1\u201314. https:\/\/doi.org\/10.1186\/s11689-015-9127-4","journal-title":"Journal of Neurodevelopmental Disorders"},{"issue":"7","key":"6238_CR5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jval.2017.05.015","volume":"20","author":"K Benjamin","year":"2017","unstructured":"Benjamin, K., Vernon, M. K., Patrick, D. L., Perfetto, E., Nestler-Parr, S., & Burke, L. (2017). Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: An ISPOR COA emerging good practices task force report. Value in Health, 20(7), 838\u2013855. https:\/\/doi.org\/10.1016\/j.jval.2017.05.015","journal-title":"Value in Health"},{"issue":"7","key":"6238_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/dbp.0b013e31829d1f20","volume":"34","author":"E Berry-Kravis","year":"2013","unstructured":"Berry-Kravis, E., Hessl, D., Abbeduto, L., Reiss, A. L., Beckel-Mitchener, A., Urv, T. K., Group, O. M. W. (2013). Outcome measures for clinical trials in fragile X syndrome. Journal of Developmental and Behavioral Pediatrics, 34(7), 508. https:\/\/doi.org\/10.1097\/dbp.0b013e31829d1f20","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"2","key":"6238_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.braindev.2018.08.008","volume":"41","author":"CB Buchanan","year":"2019","unstructured":"Buchanan, C. B., Stallworth, J. L., Scott, A. E., Glaze, D. G., Lane, J. B., Skinner, S. A., & Kaufmann, W. E. (2019). Behavioral profiles in Rett syndrome: Data from the natural history study. Brain and Development, 41(2), 123\u2013134. https:\/\/doi.org\/10.1016\/j.braindev.2018.08.008","journal-title":"Brain and Development"},{"issue":"9","key":"6238_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.4155\/cli.11.113","volume":"1","author":"K Bushby","year":"2011","unstructured":"Bushby, K., & Connor, E. (2011). Clinical outcome measures for trials in Duchenne muscular dystrophy: Report from International Working Group meetings. Clinical Investigation, 1(9), 1217. https:\/\/doi.org\/10.4155\/cli.11.113","journal-title":"Clinical Investigation"},{"issue":"6","key":"6238_CR9","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s11011-018-0316-1","volume":"33","author":"S Corch\u00f3n","year":"2018","unstructured":"Corch\u00f3n, S., Carrillo-L\u00f3pez, I., & Cauli, O. (2018). Quality of life related to clinical features in patients with Rett syndrome and their parents: A systematic review. Metabolic Brain Disease, 33(6), 1801\u20131810. https:\/\/doi.org\/10.1007\/s11011-018-0316-1","journal-title":"Metabolic Brain Disease"},{"issue":"3","key":"6238_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1530\/boneabs.7.p118","volume":"51","author":"VA Cuddapah","year":"2014","unstructured":"Cuddapah, V. A., Pillai, R. B., Shekar, K. V., Lane, J. B., Motil, K. J., Skinner, S. A., & Olsen, M. L. (2014). Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. Journal of Medical Genetics, 51(3), 152\u2013158. https:\/\/doi.org\/10.1530\/boneabs.7.p118","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"6238_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1352\/1944-7558-122.3.247","volume":"122","author":"AJ Esbensen","year":"2017","unstructured":"Esbensen, A. J., Hooper, S. R., Fidler, D., Hartley, S. L., Edgin, J., d\u2019Ardhuy, X. L., Group, O. M. W. (2017). Outcome measures for clinical trials in Down syndrome. American Journal on Intellectual and Developmental Disabilities, 122(3), 247\u2013281. https:\/\/doi.org\/10.1352\/1944-7558-122.3.247","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"key":"6238_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1023\/b:jadd.0000005999.27178.55","volume":"33","author":"AJ Esbensen","year":"2003","unstructured":"Esbensen, A. J., Rojahn, J., Aman, M. G., & Ruedrich, S. (2003). Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders, 33, 617\u2013629. https:\/\/doi.org\/10.1023\/b:jadd.0000005999.27178.55","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"6238_CR100","doi-asserted-by":"crossref","unstructured":"Farmer, C., Kaat, A. J., Berry-Kravis, E., & Thurm, A. (2022). Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder. In International review of research in developmental disabilities (Vol. 62, pp. 1\u201339). Academic Press.","DOI":"10.1016\/bs.irrdd.2022.05.001"},{"issue":"4","key":"6238_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/135245859900500409","volume":"5","author":"JS Fischer","year":"1999","unstructured":"Fischer, J. S., Rudick, R. A., Cutter, G. R., Reingold, S. C., National MS Society Clinical Outcomes Assessment Task Force. (1999). The multiple sclerosis functional composite measure (MSFC): An integrated approach to MS clinical outcome assessment. Multiple Sclerosis Journal, 5(4), 244\u2013250. https:\/\/doi.org\/10.1177\/135245859900500409","journal-title":"Multiple Sclerosis Journal"},{"key":"6238_CR14","unstructured":"Food and Drug Administration (March, 2023). FDA approves first treatment for Rett Syndrome. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-treatment-rett-syndrome#:~:text=FDA%20has%20approved%20Daybue%20(trofinetide,orally%20or%20via%20gastrostomy%20tube. Accessed November 30, 2023."},{"key":"6238_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000717","author":"C Fu","year":"2020","unstructured":"Fu, C., Armstrong, D., Marsh, E., Lieberman, D., Motil, K., Witt, R., & Benke, T. (2020). Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatrics Open. https:\/\/doi.org\/10.1136\/bmjpo-2020-000717","journal-title":"BMJ Paediatrics Open"},{"issue":"16","key":"6238_CR16","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.1212\/wnl.0000000000007316","volume":"92","author":"DG Glaze","year":"2019","unstructured":"Glaze, D. G., Neul, J. L., Kaufmann, W. E., Berry-Kravis, E., Condon, S., Stoms, G., & Percy, A. K. (2019). Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. Neurology, 92(16), e1912\u2013e1925. https:\/\/doi.org\/10.1212\/wnl.0000000000007316","journal-title":"Neurology"},{"key":"6238_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","volume":"76","author":"DG Glaze","year":"2017","unstructured":"Glaze, D. G., Neul, J. L., Percy, A., Feyma, T., Beisang, A., Yaroshinsky, A., & Jones, N. E. (2017). A double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of Rett syndrome. Pediatric Neurology, 76, 37\u201346. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.07.002","journal-title":"Pediatric Neurology"},{"issue":"5815","key":"6238_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3410\/f.1066718.519633","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315(5815), 1143\u20131147. https:\/\/doi.org\/10.3410\/f.1066718.519633","journal-title":"Science"},{"issue":"4","key":"6238_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410140412","volume":"14","author":"B Hagberg","year":"1983","unstructured":"Hagberg, B., Aicardi, J., Dias, K., & Ramos, O. (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett\u2019s syndrome: Report of 35 cases. Annals of Neurology, 14(4), 471\u2013479. https:\/\/doi.org\/10.1002\/ana.410140412","journal-title":"Annals of Neurology"},{"key":"6238_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2020.01.009","volume":"107","author":"W Hou","year":"2020","unstructured":"Hou, W., Bhattacharya, U., Pradana, W. A., & Tarquinio, D. C. (2020). Assessment of a clinical trial metric for Rett syndrome: Critical analysis of the Rett syndrome behavioural questionnaire. Pediatric Neurology, 107, 48\u201356. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2020.01.009","journal-title":"Pediatric Neurology"},{"issue":"7","key":"6238_CR21","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/epi.17247","volume":"63","author":"EN Hurley","year":"2022","unstructured":"Hurley, E. N., Ellaway, C. J., Johnson, A. M., Truong, L., Gordon, R., Galettis, P., & Lawson, J. A. (2022). Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia, 63(7), 1736\u20131747. https:\/\/doi.org\/10.1111\/epi.17247","journal-title":"Epilepsia"},{"issue":"2","key":"6238_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tins.2015.12.008","volume":"39","author":"DM Katz","year":"2016","unstructured":"Katz, D. M., Bird, A., Coenraads, M., Gray, S. J., Menon, D. U., Philpot, B. D., & Tarquinio, D. C. (2016). Rett syndrome: Crossing the threshold to clinical translation. Trends in Neurosciences, 39(2), 100\u2013113. https:\/\/doi.org\/10.1016\/j.tins.2015.12.008","journal-title":"Trends in Neurosciences"},{"key":"6238_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2015.12.021","volume":"58","author":"JT Killian Jr","year":"2016","unstructured":"Killian, J. T., Jr., Lane, J. B., Lee, H. S., Pelham, J. H., Skinner, S. A., Kaufmann, W. E., & Percy, A. K. (2016). Caretaker quality of life in Rett syndrome: Disorder features and psychological predictors. Pediatric Neurology, 58, 67\u201374. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.12.021","journal-title":"Pediatric Neurology"},{"key":"6238_CR24","volume-title":"The CHQ user\u2019s manual","author":"JM Landgraf","year":"1996","unstructured":"Landgraf, J. M., Abetz, L., & Ware, J. E. (1996). The CHQ user\u2019s manual (1st ed.). The Health Institute, New England Medical Center.","edition":"1"},{"issue":"20","key":"6238_CR25","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1212\/wnl.0b013e3182377dd2","volume":"77","author":"JB Lane","year":"2011","unstructured":"Lane, J. B., Lee, H. S., Smith, L. W., Cheng, P., Percy, A. K., Glaze, D. G., & Krischer, J. P. (2011). Clinical severity and quality of life in children and adolescents with Rett syndrome. Neurology, 77(20), 1812\u20131818. https:\/\/doi.org\/10.1212\/wnl.0b013e3182377dd2","journal-title":"Neurology"},{"issue":"Suppl 1","key":"6238_CR26","first-page":"8","volume":"6","author":"H Leonard","year":"1997","unstructured":"Leonard, H., Bower, C., & English, D. (1997). The prevalence and incidence of Rett syndrome in Australia. European Child & Adolescent Psychiatry, 6(Suppl 1), 8\u201310. PMID: 9452912.","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"1","key":"6238_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02240-w","volume":"17","author":"H Leonard","year":"2022","unstructured":"Leonard, H., Gold, W., Samaco, R., Sahin, M., Benke, T., & Downs, J. (2022). Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome. Orphanet Journal of Rare Diseases, 17(1), 1\u201315. https:\/\/doi.org\/10.1186\/s13023-022-02240-w","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"8","key":"6238_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/1469-7610.00236","volume":"43","author":"RH Mount","year":"2002","unstructured":"Mount, R. H., Charman, T., Hastings, R. P., Reilly, S., & Cass, H. (2002). The Rett syndrome behaviour questionnaire (RSBQ): Refining the behavioural phenotype of Rett syndrome. Journal of Child Psychology and Psychiatry, 43(8), 1099\u20131110. https:\/\/doi.org\/10.1111\/1469-7610.00236","journal-title":"Journal of Child Psychology and Psychiatry"},{"key":"6238_CR29","unstructured":"Muth\u00e9n, L. K. and Muth\u00e9n, B. O. (1998\u20132017). Mplus user\u2019s guide (8th ed.). Muth\u00e9n & Muth\u00e9n"},{"key":"6238_CR30","unstructured":"National Library of Medicine (2023a). Safety and Efficacy of TSHA-102 in Adult Females With Rett Syndrome (REVEAL Adult Study). https:\/\/clinicaltrials.gov\/study\/NCT05606614. Accessed November 29, 2023."},{"key":"6238_CR31","unstructured":"National Library of Medicine (2023b). A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome. https:\/\/clinicaltrials.gov\/study\/NCT05898620. Accessed November 29, 2023."},{"key":"6238_CR32","doi-asserted-by":"crossref","unstructured":"Neul, J. L., Benke, T. A., Marsh, E. D., Suter, B., Silveira, L., Fu, C., \u2026 & Percy, A. K. (2023). Top caregiver concerns in Rett syndrome and related disorders; Data from the U. S. Natural History Study. Preprint: https:\/\/www.researchsquare.com\/article\/rs-2566253\/v1","DOI":"10.1186\/s11689-023-09502-z"},{"issue":"1","key":"6238_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","volume":"180","author":"JL Neul","year":"2019","unstructured":"Neul, J. L., Benke, T. A., Marsh, E. D., Skinner, S. A., Merritt, J., Lieberman, D. N., & Percy, A. K. (2019). The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 180(1), 55\u201367. https:\/\/doi.org\/10.1002\/ajmg.b.32707","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"issue":"16","key":"6238_CR34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","volume":"70","author":"JL Neul","year":"2008","unstructured":"Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., & Glaze, D. G. (2008). Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology, 70(16), 1313\u20131321. https:\/\/doi.org\/10.1212\/01.wnl.0000291011.54508.aa","journal-title":"Neurology"},{"issue":"13","key":"6238_CR35","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1177\/0883073815579707","volume":"30","author":"JL Neul","year":"2015","unstructured":"Neul, J. L., Glaze, D. G., Percy, A. K., Feyma, T., Beisang, A., Dinh, T., & Jones, N. E. (2015). Improving treatment trial outcomes for Rett syndrome: The development of Rett-specific anchors for the clinical global impression scale. Journal of Child Neurology, 30(13), 1743\u20131748. https:\/\/doi.org\/10.1177\/0883073815579707","journal-title":"Journal of Child Neurology"},{"issue":"6","key":"6238_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","volume":"68","author":"JL Neul","year":"2010","unstructured":"Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi-Buisson, N., RettSearch Consortium (Members listed in the Appendix). (2010). Rett syndrome: Revised diagnostic criteria and nomenclature. Annals of Neurology, 68(6), 944\u2013950. https:\/\/doi.org\/10.1002\/ana.22124","journal-title":"Annals of Neurology"},{"issue":"1","key":"6238_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1866-1955-6-20","volume":"6","author":"JL Neul","year":"2014","unstructured":"Neul, J. L., Lane, J. B., Lee, H. S., Geerts, S., Barrish, J. O., Annese, F., & Percy, A. K. (2014). Developmental delay in Rett syndrome: Data from the natural history study. Journal of Neurodevelopmental Disorders, 6(1), 1\u20139. https:\/\/doi.org\/10.1186\/1866-1955-6-20","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"6238_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02398-1","author":"JL Neul","year":"2023","unstructured":"Neul, J. L., Percy, A. K., Benke, T. A., Berry-Kravis, E. M., Glaze, D. G., Marsh, E. D., & Youakim, J. M. (2023). Trofinetide for the treatment of Rett syndrome: A randomized Phase 3 study. Nature Medicine. https:\/\/doi.org\/10.1038\/s41591-023-02398-1","journal-title":"Nature Medicine"},{"key":"6238_CR39","doi-asserted-by":"publisher","first-page":"106704","DOI":"10.1016\/j.cct.2022.106704","volume":"114","author":"JL Neul","year":"2022","unstructured":"Neul, J. L., Percy, A. K., Benke, T. A., Berry-Kravis, E. M., Glaze, D. G., Peters, S. U., & Youakim, J. M. (2022). Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemporary Clinical Trials, 114, 106704. https:\/\/doi.org\/10.1016\/j.cct.2022.106704","journal-title":"Contemporary Clinical Trials"},{"issue":"2","key":"6238_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/dmcn.15383","volume":"65","author":"N Panayotis","year":"2023","unstructured":"Panayotis, N., Ehinger, Y., Felix, M. S., & Roux, J. C. (2023). State-of-the-art therapies for Rett syndrome. Developmental Medicine & Child Neurology, 65(2), 162\u2013170. https:\/\/doi.org\/10.1111\/dmcn.15383","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"3","key":"6238_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s13311-015-0353-y","volume":"12","author":"L Pozzo-Miller","year":"2015","unstructured":"Pozzo-Miller, L., Pati, S., & Percy, A. K. (2015). Rett syndrome: Reaching for clinical trials. Neurotherapeutics, 12(3), 631\u2013640. https:\/\/doi.org\/10.1007\/s13311-015-0353-y","journal-title":"Neurotherapeutics"},{"issue":"6","key":"6238_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1352\/1944-7558-125.6.493","volume":"125","author":"M Raspa","year":"2020","unstructured":"Raspa, M., Bann, C. M., Gwaltney, A., Benke, T. A., Fu, C., Glaze, D. G., & Neul, J. L. (2020). A psychometric evaluation of the motor-behavioral assessment scale for use as an outcome measure in Rett syndrome clinical trials. American Journal on Intellectual and Developmental Disabilities, 125(6), 493\u2013509. https:\/\/doi.org\/10.1352\/1944-7558-125.6.493","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"issue":"5\u20136","key":"6238_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/fbp.0b013e32830c3645","volume":"19","author":"L Ricceri","year":"2008","unstructured":"Ricceri, L., De Filippis, B., & Laviola, G. (2008). Mouse models of Rett syndrome: From behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behavioural Pharmacology, 19(5\u20136), 501\u2013517. https:\/\/doi.org\/10.1097\/fbp.0b013e32830c3645","journal-title":"Behavioural Pharmacology"},{"issue":"9","key":"6238_CR44","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/brain\/aws096","volume":"135","author":"L Robinson","year":"2012","unstructured":"Robinson, L., Guy, J., McKay, L., Brockett, E., Spike, R. C., Selfridge, J., & Cobb, S. R. (2012). Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain, 135(9), 2699\u20132710. https:\/\/doi.org\/10.1093\/brain\/aws096","journal-title":"Brain"},{"issue":"4","key":"6238_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., & Tabrizi, S. J. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204\u2013216. https:\/\/doi.org\/10.1038\/nrneurol.2014.24","journal-title":"Nature Reviews Neurology"},{"issue":"6","key":"6238_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3200\/joer.99.6.323-338","volume":"99","author":"JB Schreiber","year":"2006","unstructured":"Schreiber, J. B., Nora, A., Stage, F. K., Barlow, E. A., & King, J. (2006). Reporting structural equation modeling and confirmatory factor analysis results: A review. The Journal of Educational Research, 99(6), 323\u2013338. https:\/\/doi.org\/10.3200\/joer.99.6.323-338","journal-title":"The Journal of Educational Research"},{"issue":"17","key":"6238_CR47","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.3390\/jcm11175094","volume":"11","author":"J Singh","year":"2022","unstructured":"Singh, J., Fiori, F., Law, M. L., Ahmed, R., Ameenpur, S., Basheer, S., & Santosh, P. (2022). Development and psychometric properties of the multi-system profile of symptoms scale in patients with Rett syndrome. Journal of Clinical Medicine, 11(17), 5094. https:\/\/doi.org\/10.3390\/jcm11175094","journal-title":"Journal of Clinical Medicine"},{"key":"6238_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","volume":"2","author":"M Tavakol","year":"2011","unstructured":"Tavakol, M., & Dennick, R. (2011). Making sense of Cronbach\u2019s alpha. International Journal of Medical Education, 2, 53\u201355. https:\/\/doi.org\/10.5116\/ijme.4dfb.8dfd","journal-title":"International Journal of Medical Education"},{"issue":"6","key":"6238_CR49","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1073\/pnas.0812394106","volume":"106","author":"D Tropea","year":"2009","unstructured":"Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., & Sur, M. (2009). Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Sciences, 106(6), 2029\u20132034. https:\/\/doi.org\/10.1073\/pnas.0812394106","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"6238_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40271-020-00493-w","volume":"14","author":"A Whittal","year":"2021","unstructured":"Whittal, A., Meregaglia, M., & Nicod, E. (2021). The use of patient-reported outcome measures in rare diseases and implications for health technology assessment. The Patient \u2013 Patient-Centered Outcomes Research, 14(5), 485\u2013503. https:\/\/doi.org\/10.1007\/s40271-020-00493-w","journal-title":"The Patient \u2013 Patient-Centered Outcomes Research"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-024-06238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-024-06238-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-024-06238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:17:07Z","timestamp":1739557027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10803-024-06238-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6238"],"URL":"https:\/\/doi.org\/10.1007\/s10803-024-06238-0","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"3 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to conducting the analyses, the study was review by RTI International\u2019s Institutional Review Board. The study received a determination of Human Subjects Research, Not Engaged given all data was de-identified and there was no contact with study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}